Global Carotid Endarterectomy 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06251506

Publication Date:

June 27, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Carotid Endarterectomy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
It"s a surgical procedure performed to remove plaque buildup from the carotid arteries, which are located in the neck and supply blood to the brain. The surgery aims to reduce the risk of stroke by clearing blockages and improving blood flow in these arteries.
United States market for Carotid Endarterectomy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Carotid Endarterectomy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Carotid Endarterectomy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Carotid Endarterectomy players cover Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐arotid Endarterectomy Industry Forecast鈥� looks at past sales and reviews total world Carotid Endarterectomy sales in 2024, providing a comprehensive analysis by region and market sector of projected Carotid Endarterectomy sales for 2025 through 2031. With Carotid Endarterectomy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carotid Endarterectomy industry.
This Insight Report provides a comprehensive analysis of the global Carotid Endarterectomy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Carotid Endarterectomy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Carotid Endarterectomy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carotid Endarterectomy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carotid Endarterectomy.
This report presents a comprehensive overview, market shares, and growth opportunities of Carotid Endarterectomy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Traditional Carotid Endarterectom
Eversion Carotid Endarterectomy
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Carotid Endarterectomy 麻豆原创 Size (2020-2031)
2.1.2 Carotid Endarterectomy 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Carotid Endarterectomy by Country/Region (2020, 2024 & 2031)
2.2 Carotid Endarterectomy Segment by Type
2.2.1 Traditional Carotid Endarterectom
2.2.2 Eversion Carotid Endarterectomy
2.3 Carotid Endarterectomy 麻豆原创 Size by Type
2.3.1 Carotid Endarterectomy 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Carotid Endarterectomy 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Carotid Endarterectomy Segment by Application
2.4.1 Academic & Research Institutes
2.4.2 Pharmaceutical & Biotechnology Companies
2.4.3 Hospitals & Diagnostic Centers
2.4.4 Contract Research Organizations
2.4.5 Others
2.5 Carotid Endarterectomy 麻豆原创 Size by Application
2.5.1 Carotid Endarterectomy 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Carotid Endarterectomy 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Carotid Endarterectomy 麻豆原创 Size by Player
3.1 Carotid Endarterectomy 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Carotid Endarterectomy Revenue by Player (2020-2025)
3.1.2 Global Carotid Endarterectomy Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Carotid Endarterectomy Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Carotid Endarterectomy by Region
4.1 Carotid Endarterectomy 麻豆原创 Size by Region (2020-2025)
4.2 Global Carotid Endarterectomy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Carotid Endarterectomy 麻豆原创 Size Growth (2020-2025)
4.4 APAC Carotid Endarterectomy 麻豆原创 Size Growth (2020-2025)
4.5 Europe Carotid Endarterectomy 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Carotid Endarterectomy 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Carotid Endarterectomy 麻豆原创 Size by Country (2020-2025)
5.2 Americas Carotid Endarterectomy 麻豆原创 Size by Type (2020-2025)
5.3 Americas Carotid Endarterectomy 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carotid Endarterectomy 麻豆原创 Size by Region (2020-2025)
6.2 APAC Carotid Endarterectomy 麻豆原创 Size by Type (2020-2025)
6.3 APAC Carotid Endarterectomy 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Carotid Endarterectomy 麻豆原创 Size by Country (2020-2025)
7.2 Europe Carotid Endarterectomy 麻豆原创 Size by Type (2020-2025)
7.3 Europe Carotid Endarterectomy 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Carotid Endarterectomy by Region (2020-2025)
8.2 Middle East & Africa Carotid Endarterectomy 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Carotid Endarterectomy 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Carotid Endarterectomy 麻豆原创 Forecast
10.1 Global Carotid Endarterectomy Forecast by Region (2026-2031)
10.1.1 Global Carotid Endarterectomy Forecast by Region (2026-2031)
10.1.2 Americas Carotid Endarterectomy Forecast
10.1.3 APAC Carotid Endarterectomy Forecast
10.1.4 Europe Carotid Endarterectomy Forecast
10.1.5 Middle East & Africa Carotid Endarterectomy Forecast
10.2 Americas Carotid Endarterectomy Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Carotid Endarterectomy Forecast
10.2.2 Canada 麻豆原创 Carotid Endarterectomy Forecast
10.2.3 Mexico 麻豆原创 Carotid Endarterectomy Forecast
10.2.4 Brazil 麻豆原创 Carotid Endarterectomy Forecast
10.3 APAC Carotid Endarterectomy Forecast by Region (2026-2031)
10.3.1 China Carotid Endarterectomy 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Carotid Endarterectomy Forecast
10.3.3 Korea 麻豆原创 Carotid Endarterectomy Forecast
10.3.4 Southeast Asia 麻豆原创 Carotid Endarterectomy Forecast
10.3.5 India 麻豆原创 Carotid Endarterectomy Forecast
10.3.6 Australia 麻豆原创 Carotid Endarterectomy Forecast
10.4 Europe Carotid Endarterectomy Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Carotid Endarterectomy Forecast
10.4.2 France 麻豆原创 Carotid Endarterectomy Forecast
10.4.3 UK 麻豆原创 Carotid Endarterectomy Forecast
10.4.4 Italy 麻豆原创 Carotid Endarterectomy Forecast
10.4.5 Russia 麻豆原创 Carotid Endarterectomy Forecast
10.5 Middle East & Africa Carotid Endarterectomy Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Carotid Endarterectomy Forecast
10.5.2 South Africa 麻豆原创 Carotid Endarterectomy Forecast
10.5.3 Israel 麻豆原创 Carotid Endarterectomy Forecast
10.5.4 Turkey 麻豆原创 Carotid Endarterectomy Forecast
10.6 Global Carotid Endarterectomy Forecast by Type (2026-2031)
10.7 Global Carotid Endarterectomy Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Carotid Endarterectomy Forecast
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Carotid Endarterectomy Product Offered
11.1.3 Johnson & Johnson Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Carotid Endarterectomy Product Offered
11.2.3 Amgen Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Carotid Endarterectomy Product Offered
11.3.3 GlaxoSmithKline Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Information
11.4.2 Sanofi-Aventis Carotid Endarterectomy Product Offered
11.4.3 Sanofi-Aventis Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Sanofi-Aventis Main Business Overview
11.4.5 Sanofi-Aventis Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Carotid Endarterectomy Product Offered
11.5.3 Merck Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Sangamo BioSciences
11.6.1 Sangamo BioSciences Company Information
11.6.2 Sangamo BioSciences Carotid Endarterectomy Product Offered
11.6.3 Sangamo BioSciences Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Sangamo BioSciences Main Business Overview
11.6.5 Sangamo BioSciences Latest Developments
11.7 Aldagen
11.7.1 Aldagen Company Information
11.7.2 Aldagen Carotid Endarterectomy Product Offered
11.7.3 Aldagen Carotid Endarterectomy Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Aldagen Main Business Overview
11.7.5 Aldagen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.